Dr Vijay Chiruvulu
Dr. Vijay Chiruvolu has had close to 22 years of biopharmaceutical industry experience in process development, manufacturing, risk management and Quality. Currently, Dr. Chiruvolu is Vice President of Process Development at Kite Pharma, a Gilead Sciences Company, responsible for process design, tech transfer, process automation, analytical development, validation and manufacturing support of T-cell therapy processes. Before joining Kite Pharma in 2014, Dr. Chiruvolu worked as Director of Corporate Quality at Amgen. As network leader, he provided strategic direction to Amgen sites in the areas of equipment, sterilization, cleaning, process, and packaging and transportation validations. Previously Dr. Chiruvolu was the Director of Risk Management and was responsible for implementing ICHQ9, risk modeling and training of risk facilitators. He also was the Director of Process Engineering providing manufacturing support of upstream and downstream processes.
Dr. Chiruvolu holds a PhD in biochemical engineering and an MBA.